Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies

Cytomegalovirus (CMV) infection/disease has been repeatedly reported in patients treated with immune-checkpoint inhibitors (ICIs) and most commonly involves patients with relapsed/refractory (R/R) immune-related adverse events (irAEs). In the current study, we present a patient with melanoma who dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastasopoulou, Amalia, Samarkos, Michael, Diamantopoulos, Panagiotis, Vourlakou, Christina, Ziogas, Dimitrios C, Avramopoulos, Pantelis, Kouzis, Panagiotis, Haanen, John, Gogas, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099470/
https://www.ncbi.nlm.nih.gov/pubmed/37065986
http://dx.doi.org/10.1093/ofid/ofad164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099470/
https://www.ncbi.nlm.nih.gov/pubmed/37065986
http://dx.doi.org/10.1093/ofid/ofad164

Ejemplares similares